Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
pneumococcal infections
MeSH D011008 - pneumococcal infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D013290:
Streptococcal infections
171 Companies
81 Drugs
$
Success rate
D011008:
Â
Pneumococcal infections
37 Companies
9 Drugs
$
Success rate
D008586:
Pneumococcal meningitis
36 Companies
3 Drugs
$
Success rate
D011018:
Pneumococcal pneumonia
1 Company
1 Drug
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/2
Phase 2
0
%
0/2
Phase 3
100
%
6/6
Approved:
6
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
GSK
Penicillin v
,
Ampicillin
,
Bevifimod
,
Synflorix
,
Fendrix
,
Fluzone
,
Prevenar13
,
Prevnar13
,
Pcv13
,
Pneumovax
,
Flumist
,
Pcv
,
Flucelvax
,
Prevenar
Wyeth
Pneumovax
,
Prevenar
Merck & Co
Antithrombin iii
,
Enoblituzumab
,
Ademetionine
,
Sodium chloride
,
Sodium lactate
,
Bevifimod
,
Microcrystalline cellulose
,
Foster
,
Recombivax
,
V114
,
Fendrix
,
Fluzone
,
Prevenar13
,
Prevnar13
,
Ppv23
,
Pcv13
,
Pneumovax
,
Hsct
,
Ipv
,
Flumist
,
Pcv
,
Flucelvax
,
Prevenar
,
Zostavax
Pfizer
Penicillin v
,
Penicillin g benzathine
,
Penicillin g procaine
,
Ampicillin
,
Lincomycin
,
Penicillin g
,
Sulbactam
,
Ademetionine
,
Sodium chloride
,
Fluzone
,
Prevenar13
,
Prevnar13
,
Ppv23
,
Pcv13
,
Pneumovax
,
Arm1
,
Flumist
,
Pcv
,
Arm2
,
Flucelvax
,
Prevenar
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use